State Street Corp Instil Bio, Inc. Transaction History

State Street Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.51 - $0.67 $551,575 - $724,618	-1,081,520 Reduced 81.12%	251,650 $138,000
Q1 2023 May 15, 2023	BUY	$0.6 - $0.91 $24,874 - $37,726	41,458 Added 3.21%	1,333,170 $879,000
Q4 2022 Feb 14, 2023	BUY	$0.48 - $5.33 $82,454 - $915,587	171,780 Added 15.34%	1,291,712 $813,000
Q3 2022 Nov 15, 2022	BUY	$4.65 - $7.37 $903,987 - $1.43 Million	194,406 Added 21.0%	1,119,932 $5.42 Million
Q2 2022 Aug 15, 2022	BUY	$4.21 - $11.15 $295,845 - $783,532	70,272 Added 8.22%	925,526 $4.28 Million
Q1 2022 May 16, 2022	BUY	$8.48 - $18.1 $794,423 - $1.7 Million	93,682 Added 12.3%	855,254 $9.19 Million
Q4 2021 Feb 14, 2022	BUY	$15.37 - $22.5 $7.2 Million - $10.5 Million	468,679 Added 160.02%	761,572 $13 Million
Q3 2021 Nov 15, 2021	BUY	$15.05 - $23.28 $644,621 - $997,128	42,832 Added 17.13%	292,893 $5.24 Million
Q2 2021 Aug 16, 2021	BUY	$15.31 - $24.63 $3.83 Million - $6.16 Million	250,061 New	250,061 $4.83 Million

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.84B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.